3,4-Dimethoxyphenylacetonitrile | CAS:93-17-4

We serve 3,4-Dimethoxyphenylacetonitrile CAS:93-17-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-Dimethoxyphenylacetonitrile

Chemical Name:   3,4-Dimethoxyphenylacetonitrile
CAS.NO:  93-17-4
Synonyms:
Benzeneacetonitrile, 3,4-dimethoxy-
2-(3,4-dimethoxyphenyl)acetonitrile

Molecular Formula:C10H11NO2
Molecular Weight: 177.20000

Physical and Chemical Properties:
Density: 1.082 g / cm3
Boiling point: 171-178 ° C10 mm Hg (lit.)
Melting point: 54-57 ° C (lit.)
Flash point:> 230 ° F
Refractive index: 1.511

Specification:
Appearance: White or off white crystaline powder
Purity:≥99%
Water:0.5% max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Verapamil Hydrochloride CAS:23313-68-0



Contact us for information like 3,4-Dimethoxyphenylacetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3,4-dimethoxyphenyl)acetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzeneacetonitrile, 3,4-dimethoxy- Use and application,Benzeneacetonitrile, 3,4-dimethoxy- technical grade,usp/ep/jp grade.


Related News: The company has now selected a single engineered iPSC clone, and generated and fully-characterized the master engineered iPSC bank for GMP production of FT819.2-Ethoxythiazole manufacturer Here’s what we can tell you so far:5-Methyl-3-nitropicolinonitrile supplier Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.2-Fluoro-3-Chloro-5-Bromopyridine vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.